Global Alpha 1 Antitrypsin Deficiency Treatment Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 13, 2020 | 182 PAGES | REPORT CODE: CMM357210

REPORT SUMMARY
TABLE OF CONTENTS
INDUSTRY COVERAGE

Severe deficiency of alpha-1 antitrypsin (AAT) can cause early-onset emphysema and several liver diseases, including cirrhosis, neonatal hepatitis and hepatocellular carcinoma. The discovery of the structure and function of the AAT protein and the subsequent isolation and purification thereof have made possible alternative therapies aimed at preventing the progression of related pulmonary diseases (so-called "additional therapies"). The isolation of this gene and the advancement of gene therapy have further increased the possibility of specific treatment. Most specific treatments for AAT deficiency aim to increase plasma AAT levels (and thus elevated AAT concentrations in the interstitial lung) above the protection threshold. Other experimental therapeutic approaches attempt to interfere with the production of abnormal AAT proteins or to inhibit the polymerization of abnormal AAT proteins and to promote the secretion of AAT from hepatocytes. For patients with end-stage lung disease or liver disease, organ transplantation is another treatment option.

Currently, the most direct and effective way to increase AAT levels in plasma and interstitial lung is by intravenous infusion of pooled alpha-1 antitrypsin (pAAT).

The Alpha 1 Antitrypsin Deficiency Treatment is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 10.1%% during the forecast period. The research provides insights for the global Alpha 1 Antitrypsin Deficiency Treatment market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Alpha 1 Antitrypsin Deficiency Treatment industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Alpha 1 Antitrypsin Deficiency Treatment Market Segmentations:

By Players:

Pfizer
Baxter
AstraZeneca
Grifols
Teva Pharmaceutical Industries
Boehringer Ingelheim
Kamada Ltd
GlaxoSmithKline
CSL Behring
Shire
LFB Biomedicaments
Abeona Therapeutics
Biogen
Applied Genetic Technologies
Baxalta
Arrowhead Research Corporation
ProBioGen
Chiesi Pharmaceuticals
Curaxys
ProMetic Life Sciences

By Types:

Augmentation Therapy
Bronchodilators
Corticosteroids
Oxygen Therapy

By End-User:

Hospitals
Specialty Clinics
Pharmacies

By Regions:

North America

United States
Canada
Mexico

Europe

Germany
UK
France
Italy
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
Spain
Belgium
Poland
Russia
Turkey
Others

Asia-Pacific

China
Japan
India
South Korea
Australia and New Zealand
ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
Brazil
Nigeria
South Africa
Argentina
Others

Table of Contents

1 Report Overview

1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Alpha 1 Antitrypsin Deficiency Treatment Market
1.3 Market Segmentation by Type

1.3.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Augmentation Therapy from 2014 to 2026
1.3.2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Bronchodilators from 2014 to 2026
1.3.3 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Corticosteroids from 2014 to 2026
1.3.4 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Oxygen Therapy from 2014 to 2026

1.4 Market Segmentation by End-Users

1.4.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Hospitals from 2014 to 2026
1.4.2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Specialty Clinics from 2014 to 2026
1.4.3 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Pharmacies from 2014 to 2026

1.5 Market Segmentation by Regions

1.5.1 North America Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

1.5.1.1 United States Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.1.2 Canada Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.1.3 Mexico Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

1.5.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

1.5.2.1 Germany Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.2.2 UK Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.2.3 France Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.2.4 Italy Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.2.5 Nordic Countries Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.2.6 Spain Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.2.7 Belgium Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.2.8 Poland Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.2.9 Russia Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.2.10 Turkey Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

1.5.3 Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

1.5.3.1 China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.3.2 Japan Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.3.3 Australia and New Zealand Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.3.4 India Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.3.5 ASEAN Countries Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.3.6 South Korea Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

1.5.4 Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

1.5.4.1 GCC Countries Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.4.2 Brazil Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.4.3 Nigeria Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.4.4 South Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026
1.5.4.5 Argentina Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

2.1 Market Trends and Dynamics

2.1.1 Market Challenges and Restraints
2.1.2 Market Opportunities and Potentials
2.1.3 Mergers and Acquisitions

2.2 Competitive Landscape Analysis

2.2.1 Industrial Concentration Analysis
2.2.2 Porter's Five Forces Analysis of the Industry
2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Alpha 1 Antitrypsin Deficiency Treatment Market by Types

3.1 Product Development Trends of Different Types
3.2 Commercial Product Types of Major Vendors
3.3 Competitive Landscape Analysis of Different Types
3.4 Market Size of Alpha 1 Antitrypsin Deficiency Treatment by Major Types

3.4.1 Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Augmentation Therapy
3.4.2 Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Bronchodilators
3.4.3 Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Corticosteroids
3.4.4 Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Oxygen Therapy

4 Segmentation of Alpha 1 Antitrypsin Deficiency Treatment Market by End-Users

4.1 Downstream Client Analysis by End-Users
4.2 Competitive Landscape Analysis of Different End-Users
4.3 Market Potential Analysis of Different End-Users
4.4 Market Size of Alpha 1 Antitrypsin Deficiency Treatment by Major End-Users

4.4.1 Market Size and Growth Rate of Alpha 1 Antitrypsin Deficiency Treatment in Hospitals
4.4.2 Market Size and Growth Rate of Alpha 1 Antitrypsin Deficiency Treatment in Specialty Clinics
4.4.3 Market Size and Growth Rate of Alpha 1 Antitrypsin Deficiency Treatment in Pharmacies

5 Market Analysis by Major Regions

5.1 Global Alpha 1 Antitrypsin Deficiency Treatment Production Analysis by Major Regions
5.2 Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Analysis by Major Regions
5.3 Global Alpha 1 Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis by Regions

5.3.1 North America Alpha 1 Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis
5.3.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis
5.3.3 Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis
5.3.4 Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis

6 Product Commodity of Alpha 1 Antitrypsin Deficiency Treatment Market in Major Countries

6.1 Top 5 Export Countries in Alpha 1 Antitrypsin Deficiency Treatment market from 2014 to 2019

6.1.1 Top 5 Export Countries' Export Value Analysis in Alpha 1 Antitrypsin Deficiency Treatment market from 2014 to 2019
6.1.2 Top 5 Export Countries' Export Volume Analysis in Alpha 1 Antitrypsin Deficiency Treatment market from 2014 to 2019

6.2 Top 5 Import Countries in Alpha 1 Antitrypsin Deficiency Treatment market from 2014 to 2019

6.2.1 Top 5 Import Countries' Import Value Analysis in Alpha 1 Antitrypsin Deficiency Treatment market from 2014 to 2019
6.2.2 Top 5 Import Countries' Import Volume Analysis in Alpha 1 Antitrypsin Deficiency Treatment market from 2014 to 2019

6.3 Emerging Top 3 Export Countries Analysis
6.4 Emerging Top 3 Import Countries Analysis

7 North America Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis

7.1 North America Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis by Major Types
7.2 North America Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis by Major End-Users
7.3 North America Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis by Major Countries

7.3.1 United States Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
7.3.2 Canada Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
7.3.3 Mexico Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate

8 Europe Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis

8.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis by Major Types
8.2 Europe Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis by Major End-Users
8.3 Europe Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis by Major Countries

8.3.1 Germany Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
8.3.2 UK Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
8.3.3 France Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
8.3.4 Italy Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
8.3.5 Nordic Countries Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
8.3.6 Spain Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
8.3.7 Belgium Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
8.3.8 Poland Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
8.3.9 Russia Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
8.3.10 Turkey Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate

9 Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis

9.1 Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis by Major Types
9.2 Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis by Major End-Users
9.3 Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis by Major Countries

9.3.1 China Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
9.3.2 Japan Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
9.3.3 Australia and New Zealand Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
9.3.4 India Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
9.3.5 ASEAN Countries Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
9.3.6 South Korea Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate

10 Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis

10.1 Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis by Major Types
10.2 Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis by Major End-Users
10.3 Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Landscape Analysis by Major Countries

10.3.1 GCC Countries Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
10.3.2 Brazil Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
10.3.3 Nigeria Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
10.3.4 South Africa Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate
10.3.5 Argentina Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate

11 Major Players Profile

11.1 Pfizer

11.1.1 Pfizer Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction

11.2 Baxter

11.2.1 Baxter Company Profile and Recent Development
11.2.2 Market Performance
11.2.3 Product and Service Introduction

11.3 AstraZeneca

11.3.1 AstraZeneca Company Profile and Recent Development
11.3.2 Market Performance
11.3.3 Product and Service Introduction

11.4 Grifols

11.4.1 Grifols Company Profile and Recent Development
11.4.2 Market Performance
11.4.3 Product and Service Introduction

11.5 Teva Pharmaceutical Industries

11.5.1 Teva Pharmaceutical Industries Company Profile and Recent Development
11.5.2 Market Performance
11.5.3 Product and Service Introduction

11.6 Boehringer Ingelheim

11.6.1 Boehringer Ingelheim Company Profile and Recent Development
11.6.2 Market Performance
11.6.3 Product and Service Introduction

11.7 Kamada Ltd

11.7.1 Kamada Ltd Company Profile and Recent Development
11.7.2 Market Performance
11.7.3 Product and Service Introduction

11.8 GlaxoSmithKline

11.8.1 GlaxoSmithKline Company Profile and Recent Development
11.8.2 Market Performance
11.8.3 Product and Service Introduction

11.9 CSL Behring

11.9.1 CSL Behring Company Profile and Recent Development
11.9.2 Market Performance
11.9.3 Product and Service Introduction

11.10 Shire

11.10.1 Shire Company Profile and Recent Development
11.10.2 Market Performance
11.10.3 Product and Service Introduction

11.11 LFB Biomedicaments

11.11.1 LFB Biomedicaments Company Profile and Recent Development
11.11.2 Market Performance
11.11.3 Product and Service Introduction

11.12 Abeona Therapeutics

11.12.1 Abeona Therapeutics Company Profile and Recent Development
11.12.2 Market Performance
11.12.3 Product and Service Introduction

11.13 Biogen

11.13.1 Biogen Company Profile and Recent Development
11.13.2 Market Performance
11.13.3 Product and Service Introduction

11.14 Applied Genetic Technologies

11.14.1 Applied Genetic Technologies Company Profile and Recent Development
11.14.2 Market Performance
11.14.3 Product and Service Introduction

11.15 Baxalta

11.15.1 Baxalta Company Profile and Recent Development
11.15.2 Market Performance
11.15.3 Product and Service Introduction

11.16 Arrowhead Research Corporation

11.16.1 Arrowhead Research Corporation Company Profile and Recent Development
11.16.2 Market Performance
11.16.3 Product and Service Introduction

11.17 ProBioGen

11.17.1 ProBioGen Company Profile and Recent Development
11.17.2 Market Performance
11.17.3 Product and Service Introduction

11.18 Chiesi Pharmaceuticals

11.18.1 Chiesi Pharmaceuticals Company Profile and Recent Development
11.18.2 Market Performance
11.18.3 Product and Service Introduction

11.19 Curaxys

11.19.1 Curaxys Company Profile and Recent Development
11.19.2 Market Performance
11.19.3 Product and Service Introduction

11.20 ProMetic Life Sciences

11.20.1 ProMetic Life Sciences Company Profile and Recent Development
11.20.2 Market Performance
11.20.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 111 Figures and 133 Tables)

Figure Product Picture
Figure Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Augmentation Therapy from 2014 to 2026
Figure Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Bronchodilators from 2014 to 2026
Figure Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Corticosteroids from 2014 to 2026
Figure Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Oxygen Therapy from 2014 to 2026
Figure Market Share by Type in 2014
Figure Market Share by Type in 2018
Figure Market Share by Type in 2026
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Hospitals from 2014 to 2026
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Specialty Clinics from 2014 to 2026
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate of Pharmacies from 2014 to 2026
Figure Market Share by End-User in 2014
Figure Market Share by End-User in 2018
Figure Market Share by End-User in 2026
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Canada Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Mexico Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Germany Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure UK Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure France Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Italy Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Nordic Countries Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Spain Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Belgium Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Poland Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Russia Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Turkey Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Asia-Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure China Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Australia and New Zealand Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure India Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure ASEAN Countries Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure South Korea Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure GCC Countries Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Brazil Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Nigeria Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure South Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Argentina Alpha 1 Antitrypsin Deficiency Treatment Consumption Market Size and Growth Rate from 2014 to 2026
Figure Development Trends and Industry Dynamics of Alpha 1 Antitrypsin Deficiency Treatment Industry
Figure Market Challenges and Restraints
Figure Market Opportunities and Potentials
Table Mergers and Acquisition
Figure Market Share of TOP 3 Players in 2018
Figure Market Share of TOP 5 Players in 2018
Figure Market Share of TOP 6 Players from 2014 to 2019
Figure Porter's Five Forces Analysis
Figure New Entrant SWOT Analysis
Table Specifications of Different Types of Alpha 1 Antitrypsin Deficiency Treatment
Figure Development Trends of Different Types
Table Commercial Products Types of Major Vendors
Figure Competitive Landscape Analysis of Different Types
Table Consumption of Alpha 1 Antitrypsin Deficiency Treatment by Different Types from 2014 to 2026
Table Consumption Share of Alpha 1 Antitrypsin Deficiency Treatment by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Augmentation Therapy
Figure Market Size and Growth Rate of Bronchodilators
Figure Market Size and Growth Rate of Corticosteroids
Figure Market Size and Growth Rate of Oxygen Therapy
Table Downstream Client Analysis by End-Users
Figure Competitive Landscape Analysis of Different End-Users
Table Market Potential Analysis of Different End-Users
Table Consumption of Alpha 1 Antitrypsin Deficiency Treatment by Different End-Users from 2014 to 2026
Table Consumption Share of Alpha 1 Antitrypsin Deficiency Treatment by Different End-Users from 2014 to 2026
Figure Market Size and Growth Rate of Hospitals
Figure Market Size and Growth Rate of Specialty Clinics
Figure Market Size and Growth Rate of Pharmacies
Table Global Alpha 1 Antitrypsin Deficiency Treatment Production by Major Regions
Table Global Alpha 1 Antitrypsin Deficiency Treatment Production Share by Major Regions
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Production Share by Major Regions in 2014
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Production Share by Major Regions in 2018
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Production Share by Major Regions in 2026
Table Global Alpha 1 Antitrypsin Deficiency Treatment Consumption by Major Regions
Table Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Regions
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Regions in 2014
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Regions in 2018
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Regions in 2026
Table North America Alpha 1 Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis
Table Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis
Table Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Production, Import, Consumption and Export Analysis
Table Top 5 Export Countries' Export Value Analysis in Alpha 1 Antitrypsin Deficiency Treatment market from 2014 to 2019
Table Top 5 Export Countries' Export Volume Analysis in Alpha 1 Antitrypsin Deficiency Treatment market from 2014 to 2019
Table Top 5 Import Countries' Import Value Analysis in Alpha 1 Antitrypsin Deficiency Treatment market from 2014 to 2019
Table Top 5 Import Countries' Import Volume Analysis in Alpha 1 Antitrypsin Deficiency Treatment market from 2014 to 2019
Figure Emerging Top 3 Export Countries Analysis
Figure Emerging Top 3 Import Countries Analysis
Table North America Alpha 1 Antitrypsin Deficiency Treatment Consumption by Types from 2014 to 2026
Table North America Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types from 2014 to 2026
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types in 2014
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types in 2018
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types in 2026
Table North America Alpha 1 Antitrypsin Deficiency Treatment Consumption by End-Users from 2014 to 2026
Table North America Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users from 2014 to 2026
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2014
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2018
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2026
Table North America Alpha 1 Antitrypsin Deficiency Treatment Consumption by Major Countries from 2014 to 2026
Table North America Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries from 2014 to 2026
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2014
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2018
Figure North America Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2026
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure Canada Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure Mexico Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption by Types from 2014 to 2026
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types from 2014 to 2026
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types in 2014
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types in 2018
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types in 2026
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption by End-Users from 2014 to 2026
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users from 2014 to 2026
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2014
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2018
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2026
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption by Major Countries from 2014 to 2026
Table Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries from 2014 to 2026
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2014
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2018
Figure Europe Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2026
Figure Germany Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure UK Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure France Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure Italy Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure Nordic Countries Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure Belgium Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure Poland Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure Russia Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure Turkey Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Table Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption by Types from 2014 to 2026
Table Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types from 2014 to 2026
Figure Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types in 2014
Figure Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types in 2018
Figure Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types in 2026
Table Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption by End-Users from 2014 to 2026
Table Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users from 2014 to 2026
Figure Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2014
Figure Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2018
Figure Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2026
Table Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption by Major Countries from 2014 to 2026
Table Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries from 2014 to 2026
Figure Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2014
Figure Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2018
Figure Asia Pacific Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2026
Figure China Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure Australia and New ZealandAlpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure India Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure ASEAN Countries Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure South Korea Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Table Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption by Types from 2014 to 2026
Table Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types from 2014 to 2026
Figure Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types in 2014
Figure Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types in 2018
Figure Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Types in 2026
Table Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption by End-Users from 2014 to 2026
Table Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users from 2014 to 2026
Figure Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2014
Figure Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2018
Figure Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by End-Users in 2026
Table Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption by Major Countries from 2014 to 2026
Table Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries from 2014 to 2026
Figure Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2014
Figure Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2018
Figure Latin America, Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Consumption Share by Major Countries in 2026
Figure GCC Countries Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure Brazil Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure Nigeria Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure South Africa Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Figure Argentina Alpha 1 Antitrypsin Deficiency Treatment Market Volume and Growth Rate from 2014 to 2026
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of Baxter
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter
Figure Sales and Growth Rate Analysis of Baxter
Figure Revenue and Market Share Analysis of Baxter
Table Product and Service Introduction of Baxter
Table Company Profile and Development Status of AstraZeneca
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
Figure Sales and Growth Rate Analysis of AstraZeneca
Figure Revenue and Market Share Analysis of AstraZeneca
Table Product and Service Introduction of AstraZeneca
Table Company Profile and Development Status of Grifols
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols
Figure Sales and Growth Rate Analysis of Grifols
Figure Revenue and Market Share Analysis of Grifols
Table Product and Service Introduction of Grifols
Table Company Profile and Development Status of Teva Pharmaceutical Industries
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries
Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries
Table Product and Service Introduction of Teva Pharmaceutical Industries
Table Company Profile and Development Status of Boehringer Ingelheim
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
Table Product and Service Introduction of Boehringer Ingelheim
Table Company Profile and Development Status of Kamada Ltd
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kamada Ltd
Figure Sales and Growth Rate Analysis of Kamada Ltd
Figure Revenue and Market Share Analysis of Kamada Ltd
Table Product and Service Introduction of Kamada Ltd
Table Company Profile and Development Status of GlaxoSmithKline
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
Figure Revenue and Market Share Analysis of GlaxoSmithKline
Table Product and Service Introduction of GlaxoSmithKline
Table Company Profile and Development Status of CSL Behring
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Behring
Figure Sales and Growth Rate Analysis of CSL Behring
Figure Revenue and Market Share Analysis of CSL Behring
Table Product and Service Introduction of CSL Behring
Table Company Profile and Development Status of Shire
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire
Figure Sales and Growth Rate Analysis of Shire
Figure Revenue and Market Share Analysis of Shire
Table Product and Service Introduction of Shire
Table Company Profile and Development Status of LFB Biomedicaments
Table Sales, Revenue, Sales Price and Gross Margin Analysis of LFB Biomedicaments
Figure Sales and Growth Rate Analysis of LFB Biomedicaments
Figure Revenue and Market Share Analysis of LFB Biomedicaments
Table Product and Service Introduction of LFB Biomedicaments
Table Company Profile and Development Status of Abeona Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abeona Therapeutics
Figure Sales and Growth Rate Analysis of Abeona Therapeutics
Figure Revenue and Market Share Analysis of Abeona Therapeutics
Table Product and Service Introduction of Abeona Therapeutics
Table Company Profile and Development Status of Biogen
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen
Figure Sales and Growth Rate Analysis of Biogen
Figure Revenue and Market Share Analysis of Biogen
Table Product and Service Introduction of Biogen
Table Company Profile and Development Status of Applied Genetic Technologies
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Applied Genetic Technologies
Figure Sales and Growth Rate Analysis of Applied Genetic Technologies
Figure Revenue and Market Share Analysis of Applied Genetic Technologies
Table Product and Service Introduction of Applied Genetic Technologies
Table Company Profile and Development Status of Baxalta
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxalta
Figure Sales and Growth Rate Analysis of Baxalta
Figure Revenue and Market Share Analysis of Baxalta
Table Product and Service Introduction of Baxalta
Table Company Profile and Development Status of Arrowhead Research Corporation
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arrowhead Research Corporation
Figure Sales and Growth Rate Analysis of Arrowhead Research Corporation
Figure Revenue and Market Share Analysis of Arrowhead Research Corporation
Table Product and Service Introduction of Arrowhead Research Corporation
Table Company Profile and Development Status of ProBioGen
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ProBioGen
Figure Sales and Growth Rate Analysis of ProBioGen
Figure Revenue and Market Share Analysis of ProBioGen
Table Product and Service Introduction of ProBioGen
Table Company Profile and Development Status of Chiesi Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chiesi Pharmaceuticals
Figure Sales and Growth Rate Analysis of Chiesi Pharmaceuticals
Figure Revenue and Market Share Analysis of Chiesi Pharmaceuticals
Table Product and Service Introduction of Chiesi Pharmaceuticals
Table Company Profile and Development Status of Curaxys
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Curaxys
Figure Sales and Growth Rate Analysis of Curaxys
Figure Revenue and Market Share Analysis of Curaxys
Table Product and Service Introduction of Curaxys
Table Company Profile and Development Status of ProMetic Life Sciences
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ProMetic Life Sciences
Figure Sales and Growth Rate Analysis of ProMetic Life Sciences
Figure Revenue and Market Share Analysis of ProMetic Life Sciences
Table Product and Service Introduction of ProMetic Life Sciences

REPORTS

Let’s Pullulate and Expand Your Business